Oct 2026· Cell Discovery· Vol 12· 0 citations· 59 references
Medicine
TL;DR
Cryo-electron microscopy structures of MRGPRX4 in three distinct states reveal a previously unrecognized antagonist-binding site that is structurally distinct from those engaged by agonists and establish a structural framework for the rational design of MRGPRX4 antagonists that target chronic pruritus.
Abstract
Chronic pruritus is a debilitating condition with limited treatment options, particularly in cholestatic liver diseases, where bile acid dysregulation is a known trigger. Although Mas-related G protein-coupled receptor X4 (MRGPRX4) has recently been identified as a key mediator of bile acid-induced pruritus, the structural mechanisms underlying its inhibition remain poorly understood, hindering the development of therapeutic antagonists. Here, we report the cryo-electron microscopy structures of MRGPRX4 in three distinct states: agonist-bound state, antagonist-bound state, and apo state. Our structures reveal a previously unrecognized antagonist-binding site that is structurally distinct from those engaged by agonists. Complementary functional assays and molecular dynamics simulations further demonstrate that the extracellular pocket of MRGPRX4 undergoes pronounced ligand-dependent conformational rearrangements upon binding to both the agonist and the antagonist. Collectively, these findings elucidate the conformational plasticity underlying MRGPRX4 activity modulation and establish a structural framework for the rational design of MRGPRX4 antagonists that target chronic pruritus.
GPR55 is a lipid-activated G protein-coupled receptor (GPCR) implicated in metabolism, inflammation, and neurodegeneration. Lysophosphatidylinositol (LPI) species are proposed as endogenous agonists, but progress in understanding GPR55 function has still been limited by suboptimal chemical probes. Here, we present cryo...
T. Claff, Chamalee Demalgiriya-Gamage, A. B. Mahardhika et al.· Nature Communications· 0 citations
An integrated computational framework is presented that synergistically combines enhanced-sampling molecular dynamics simulations, rigorous binding free energy calculations, and quantum chemical analyses to decipher the mechanistic basis of CU-CPT22 action and establish a robust conceptual and computational framework f...
Peng Jiao, Cheng-Liang Ni, Hao Jin et al.· Journal of Molecular Graphic...· 0 citations
The structure-activity relationships (SAR), design strategies, and molecular mechanisms of small-molecule PXR modulators from a medicinal chemistry perspective are examined and actionable strategies that integrate emerging technologies and innovative approaches to improve target selectivity and achieve more precise tra...
Meng-Yao Wang, Wu-Yi Wu, Guo-Nian Zhu et al.· European journal of medicina...· 0 citations
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a premier model for precision medicine, having moved from genetic discovery to approved therapeutics within two decades. Yet despite the clinical success of monoclonal antibodies, small interfering RNA and the newly approved oral macrocyclic-peptide inhibitor cla...
M. C. Opazo, Andrés J. Gallegos, Antar Muñoz et al.· International Journal of Mol...· 0 citations
Colchicine is a long-established anti-inflammatory agent primarily recognized for its microtubule-disrupting properties. Beyond its classical mechanism of action, potential interactions with alternative molecular targets remain incompletely understood. Given the growing relevance of glucagon-like peptide-1 receptor (GL...
K. Buran· Journal of Research in Pharm...· 0 citations
P-glycoprotein (P-gp, also known as ABCB1) is a member of the ATP-binding cassette (ABC) transporter family that protects tissues from diverse xenobiotics and contributes to multidrug resistance in cancer. Despite extensive structural, biochemical, and biophysical studies, the molecular basis of its remarkable substrat...
Jing-Yu Zhan, Chao-Ming Hsieh, Lothar Esser et al.· Drug resistance updates· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.